Two Experienced CEOs Join the Advisory Board of GTEC Startup Evolugate

GTEC startup Evolugate LLC, the biotechnology company recognized for its unique technology that enables the evolution of microorganisms used in a variety of industrial applications, is proud to announce the appointment of Russell J. Howard and Terrance J. Bruggeman to its Advisory Board.

Terrance J. Bruggeman
Bruggeman's extensive experience managing biotechnology companies, including Diversa, Inc. (now Verenium, Inc.) will be an asset to Evolugate. Mr. Bruggeman currently serves as Executive Chairman of BioTork, the spin-off company recently created from Evolugate to capitalize on the Biofuels opportunity. He also serves on a number of industry, corporate and non-profit boards.

"Evolugate’s technology creates a myriad of commercial opportunities,” said Bruggeman. “I look forward to helping guide the company to commercial success.”

Russell J. Howard
Dr. Howard currently serves as CEO of a new Cleantech company, Oakbio Inc., as well as on the boards of several leading companies and foundations in the biotechnology industry. He brings significant scientific and operational expertise having served as CEO of Maxygen, Inc., a publicly traded company, for the past eleven years. Dr. Howard has published over 140 peer-reviewed publications and received numerous awards and honors.

"Evolugate has assembled the scientific and technology expertise to exploit the breakthrough new technology of “microbial evolution on demand” developed by Evolugate. I am excited to advise the team as they seek to capitalize on their unique technology capabilities to develop products in a diversity of business areas,” said Howard.

About Evolugate, LLC—
Founded in 2005, Evolugate, LLC is a privately owned biotechnology company, operating in the nascent field of experimental evolution and genomic engineering of microorganisms for diverse industrial purposes. Evolugate’s technology exploits the power of Darwinian evolution and natural selection for tuning and optimizing the phenotype of any cell to provide it with superior commercial relevance. Evolugate’s technology can be used to rapidly produce optimally adapted and efficient strains for virtually any application, including the conversion of biomass to biofuels, biopesticides and the improvement of any industrial bioprocess. Evolugate’s technology offers the possibility to improve existing bio-processes as well as to create new ones through the utilization of a reliable and proprietary continuous culture technology, which improves microorganisms by natural evolution and
selection. The company is located in Gainesville, Florida and is a participant of the Gainesville Technology Enterprise Center (GTEC) incubator program.

For more inforamtion about Evolugate, visit www.evolugate.com.
For more inforamtion about GTEC, visit www.GTECFlorida.com.